ProciseDx is a provider of point-of-care testing solutions for use in physician offices, retail clinics, and urgent care.
ProciseDx has raised $13.0M in total funding. The most recent round was Convertible Note. The last funding was announced in July 2021.
ProciseDx's investors include Nestlé Health Science.
ProciseDx is headquartered in San Diego, United States.
ProciseDx is a provider of point-of-care testing solutions for use in physician offices, retail clinics, and urgent care.
ProciseDx is at the Convertible Note stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ProciseDx — Funding & Investors." VCBacked, July 13, 2021, https://www.vcbacked.co/company/procisedx. Accessed November 13, 2026.
VCBacked. (2021). ProciseDx — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/procisedx
{{cite web |title=ProciseDx — Funding & Investors |url=https://www.vcbacked.co/company/procisedx |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at ProciseDx? Request a listing update